BIIB129 is a covalent, selective inhibitor of Brutons tyrosine kinase (BTK) capable of penetrating the blood-brain barrier. BIIB129 inhibits the activity of BTK by covalently binding to Cys481 in BTK, thereby affecting the function of B cells and myeloid cells.
Molecular Weight:
366.42
Purity:
>99.0%
CAS Number:
[2770960-52-4]
Formula:
C19H22N6O2
Target:
BTK
* VAT and and shipping costs not included. Errors and price changes excepted